DHANUSH MAKAMUncategorized1 week ago6 Views
Catalio Capital Management announced the closing of its more than $400 million Fund IV. The fund will continue the firm’s thesis of backing healthcare and biotechnology companies.
Save my name, email, and website in this browser for the next time I comment.
Uncategorized5 months ago
Uncategorized1 month ago
I consent to receive newsletter via email. For further information, please review our Privacy Policy
Uncategorized1 week ago
Uncategorized4 months ago
BREAKING NEWS6 months ago
Uncategorized6 months ago
Uncategorized1 hour ago
Uncategorized10 hours ago
Uncategorized11 hours ago
Uncategorized12 hours ago
Signing-in 3 seconds...
Signing-up 3 seconds...
Not a member? Sign Up.
Have an account? Sign In.